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sIntroduction
Most  non-Hodgkin’s  lymphomas  (NHL)  in  the  head  and  neck
region  develop  in  the  extranodal  lymphatic  system  of  the
Waldeyer  ring.1 Within  the  Waldeyer  ring,  the  nasopharynx
is  the  second  most  common  site  of  disease  after  the  ton-
sil.  Primary  nasopharyngeal  lymphoma  is  much  less  common,
occurring  in  only  8%  of  all  NHL  of  the  head  and  neck,2 and
diffuse  large  B-cell  lymphoma  (DLBCL)  is  the  most  common
histologic  type.3 Mantle  cell  lymphoma  (MCL)  is  a  distinct
subtype  of  B-cell  lymphoma  and  comprises  approximately
5--10%  of  all  lymphomas.4 MCL  is  characterized  by  an  aggres-
sive  clinical  course,  and  there  is  a  pattern  of  frequent
relapse  after  conventional  chemotherapy.4 MCLs  involving
the  nasopharynx  and  oropharynx  are  extremely  rare,  and
have  not  been  reported  in  the  literature,  to  the  best  of  the
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reserved.uthors’  knowledge.  This  case  report  describes  a  rare  clini-
al  presentation  of  primary  MCL  arising  in  the  nasopharynx
nd  extending  to  the  oropharynx.  This  study  was  approved
y  the  institutional  review  board  of  Pusan  National  Univer-
ity  Hospital.
ase report
 66-year-old  male  with  both  nasal  obstruction  and  ear
ullness  visited  the  authors’  clinic.  He  denied  fever,  chills,
nd  weight  loss.  The  endoscopic  examination  revealed
bstruction  of  both  posterior  choanae  by  a  huge  nasopharyn-
eal  mass,  accompanied  by  necrotic  material.  No  cervical
ymphadenopathies  were  felt.  Paranasal  sinus  computed
omography  (CT)  showed  a  homogenous  solid  mass  with
ild  enhancement  involving  both  nasopharyngeal  walls  and
xtending  to  the  upper  oropharynx  (Fig.  1).  On  magnetic
esonance  (MR)  images,  the  homogenous  mass  demon-
trated  low  signal  intensity  on  T1-weighted  images  (T1WIs),
ntermediate  signal  intensity  on  T2WIs,  and  moderate
nhancement  on  gadolinium-T1WIs  (Fig.  2).  A  transnasal
ndoscopic  biopsy  of  nasopharyngeal  mass  was  performed.
istopathologic  examination  showed  diffuse  inﬁltration  of
rgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights
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eigure  1  Computed  tomography  (CT)  of  paranasal  sinus.  Co
nhanced solid  mass  from  nasopharynx  extending  to  upper  orop
mall  lymphocytic  cells  with  mild  nuclear  atypia  (Fig.  3A).
mmunochemical  staining  revealed  that  the  neoplastic  lym-
hocytes  were  strongly  positive  for  CD  20,  CD5,  and  cyclin
1  (Fig.  3B--D).  These  ﬁndings  were  consistent  with  MCL.  An
pper  gastrointestinal  endoscopy,  bone  scan,  and  CT  scan  of
he  chest,  abdomen,  and  pelvis  were  all  reported  as  normal.
a
p
o
igure  2  Magnetic  resonance  (MR)  images  of  nasopharyngeal  ma
n T1-weighted  image  (T1WI)  (A)  and  intermediate  signal  intensity
nhancement.t-enhanced  CT  images  show  a  bilateral,  homogenous,  mildly-
nx  on  axial  (A),  coronal  (B),  and  sagittal  (C)  view.
 bone  marrow  biopsy  showed  no  abnormalities.  The  patient
as  staged  IE  according  to  the  Ann  Arbor  staging  system.
he  patient  received  four  cycles  of  R-CHOP  chemotherapy
nd  radiotherapy  (total  dose,  40  Gy).  After  24  months  of
ost-therapy  follow-up,  the  patient  exhibited  no  evidence
f  residual  or  recurrent  disease.
ss.  Bilateral  nasopharyngeal  mass  reveals  low  signal  intensity
 on  T2WI  (B).  Postcontrast  image  (C)  demonstrates  moderate
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Figure  3  Histopathologic  ﬁndings  of  nasopharyngeal  mass.  (A)  Microscopic  ﬁnding  shows  diffuse  inﬁltration  of  small  lymphocytic
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Rcells with  mild  nuclear  atypia  (H&E,  ×200).  Immunohistochem
and anti-cyclin  D1  (D)  antibody  (×200).
Discussion
MCL  is  a  subtype  of  B-cell  lymphoma,  derived  from  CD5-
positive  antigen-naïve  pregerminal  center  B-cells  within
the  mantle  zone  that  surrounds  normal  germinal  center
follicles.5 MCL  cells  generally  over-express  cyclin  D1  due  to  a
t  (11:14)  chromosomal  translocation  in  the  deoxyribonucleic
acid.5,6 The  cause  is  unknown  and  no  inherited  predisposi-
tion  has  been  identiﬁed.  It  accounts  for  about  5%  of  adult
NHL  in  the  United  States,  and  moreover,  the  incidence  of
MCL  has  been  increasing  over  the  last  decade,  especially
among  elderly  patients.7 The  population  most  commonly
affected  consists  of  men  with  a  median  age  of  60  years.7
Clinically,  MCL  usually  presents  with  stage  III  or  IV  dis-
ease  and  extensive  lymphadenopathy,  hepatosplenomegaly,
and  bone  marrow  involvement.  One-quarter  of  patients  are
found  to  also  have  peripheral  blood  involvement.5 Extra-
nodal  disease  occurs  less  frequently,  but  when  present,  it
typically  may  be  found  in  the  gastrointestinal  tract  and
Waldeyer’s  ring.6 In  the  extremely  rare  cases  when  MCL
involves  the  nasopharynx,  it  presents  with  a  nasopharyngeal
mass.  Described  herein  is  the  ﬁrst  case  report  of  MCL  arising
in  the  nasopahrynx.
MCL  is  diagnosed  by  examination  of  affected  tissue,
obtained  from  a  biopsy  of  a  lymph  node,  tissue,  bone
marrow,  or  blood  phenotype,  which  shows  the  typical  mor-
phology  of  monomorphic  small-  to  medium-sized  lymphoid
cells  with  irregular  nuclear  contours.8 Immunophenotyping
is  commonly  used  with  MCL  cells  that  are  CD20+,  CD5+,
and  positive  for  cyclin  D1,  whereas  negative  for  CD10
and  Bcl-6.8 In  most  of  patients  with  MCL,  t  (11:14)  and
other  genetic  changes  cause  excess  production  of  cyclin  D1,
which  is  an  early  event  in  MCL.9 MCL  is  presently  stagedtaining  shows  strong  positivity  to  anti-CD20  (B),  anti-CD5  (C),
y  using  a  modiﬁed  Ann  Arbor  system.  This  patient  had
tage  I  disease  at  presentation,  with  lesions  of  the  naso-
harynx  and  oropharynx,  which  was  successfully  treated  by
mmunochemotherapy  with  radiotherapy.
Most  MCL  patients  receive  treatment  following  diagnosis
nd  staging.  A  number  of  chemotherapy  and  rituximab  com-
inations,  such  as  R-CHOP,  are  used  to  treat  patients  with
CL.  Although  the  addition  of  rituximab,  a monoclonal  anti-
ody,  has  signiﬁcantly  improved  the  overall  outcome,  the
ve-year  overall  survival  is  as  low  as  40%  in  MCL  patients.5,10
onclusion
he  ﬁrst  case  of  primary  MCL  arising  in  the  nasopharynx  and
xtending  to  the  oropharynx  has  been  described,  which  was
uccessfully  treated  by  immunochemotherapy  with  radio-
herapy.  This  entity  should  be  recognized  and  adequately
iagnosed  because  it  may  have  a  more  aggressive  clinical
ourse  than  other  types  of  NHL  in  the  head  and  neck.  A
etailed  morphologic  evaluation  with  thorough  immunophe-
otyping  is  essential  for  an  accurate  diagnosis.
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